medigraphic.com
ISSN 1561-2945 (Print)

2011, Number 4

<< Back Next >>

Revista Cubana de Cirugía 2011; 50 (4)

Application of the standard lymphadenectomy in gastric adenocarinoma

Aguirre FRE, de la LLera DG, Peñón GM, Álvarez PA

Language: Spanish
References: 21
Page: 500-508
PDF size: 303.78 Kb.


ABSTRACT

Objective: to report the results of the application of the standard lymphadenectomy in cases of gastric adenocarcinoma admitted in the "Celia Sánchez Manduley" Clinical Surgical University Hospital of Manzanillo, Granma province.
Methods: the 5-years postoperative survival of 132 patients operated on due to gastric adenocarcinoma that underwent lymphadenectomy of the two first ganglionic levels. The results of the epidemiological parameters were determined and the survival by Kaplan-Meier method was defined.
Results: the respiratory infections, anemia and wound sepsis were the more frequent complications, but the mechanical intestinal occlusion had a significance related to mortality. Survival was higher to all reports obtained in Cuba and better than some internationals.
Conclusions: the use of standard lymphadenectomy in cases of gastric adenocarcinoma is an essential element to establish and to improve the prognosis in these patients.


REFERENCES

  1. Bulanov D. Gastric cancer-current state of the problem. Part I. Epidemiology. Pathology. Classification. Staging. Khirurgiia (Sofiia). 2007;(4):48-59.

  2. Anuario Estadístico de Cuba. [homepage en internet]; 2007 [citado 5 de febrero de 2009]. Disponible en: http://www.one.cu/ANUARIO2007.htm

  3. Qiu D, Katanoda K, Marugame T, Sobue T. A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004). Int J Cancer. 2009 Jan 15;124(2):443-8.

  4. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English ed. Gastric Cancer. 1998;1:10-24.

  5. Crane SJ, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ. Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc. 2008 Oct;83(10):1087-94.

  6. Alsina Sarmiento S, Lago Tirador R, Díaz Salas C, Barroso M. Cáncer gástrico en el Instituto Nacional de Oncología y Radiobiología, 1976 a 1980. Rev Cubana Oncol. 1988;4(3):73-82.

  7. Aguirre Fernández RE, Peñón Guerra M, Estévez Trujillo N, Naranjo Escalante R, Fonseca Aldana M. Factores pronósticos en el cáncer gastrico, 1993-1998. Cirugía (CDC). 2000;5(1):37-42.

  8. Kang Young Lee, Sung Hoon Noh, Woo Jin Hyung, Jun Ho Lee, Ki Hyeok Lah, Seung Ho Choi, et al. Impact of Splenectomy for Lymph Node Dissection on Long- Term Surgical Outcome in Gastric Cancer. Ann Surg Oncol. 2001;8:402-6.

  9. Aguirre RE, Fonseca Aldana M, Valle Gamboa M, Estévez Trujillo N, Vargas La O F. Indicaciones de la esplenectomía en el cáncer gástrico. Multimed [serie en internet] 2001 [citado 24 de marzo de 2010];5(3). Disponible en: http://www.golfo.grm.sld.cu/bvirtual/multimed/frasetmulti.htm

  10. Cisco RM, Norton JA. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions. Future Oncology. August 2008;4(4):553-9.

  11. Kim N, Park RY, Cho SI, Lim SH, Lee KH, Lee W, et al. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. J Clin Gastroenterol. 2008 May-Jun;42(5):448-54.

  12. Stewart SL, Cardinez CJ, Richardson LC, Norman L, Kaufmann R, Pechacek TF, et al. Centers for Disease Control and Prevention (CDC). Surveillance for cancers associated with tobacco use—United States, 1999-2004. MMWR Surveill Summ. 2008 Sep 5;57(8):1-33.

  13. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007;10(2):75-83.

  14. Zaragosí JL, Zaragosí A, Zaragoza C, Zaragosí J. Etiopatogenia del cáncer de muñón gástrico. Cir Esp. 2002;71:333.

  15. Majan R, El-Omar EM, Lissowska J, Grillo P, Rabkin Ch. S, Baccarelli A, et al. Genetic Variants in T Helper Cell Type 1, 2 and 3 Pathways and Gastric Cancer Risk in a Polish Population. Japanese Journal of Clinical Oncology. 2008;38(9):626-33.

  16. Piñol Jiménez F, Paniagua Estévez M. Cáncer gástrico: factores de riesgo. Rev Cubana de Oncol. 1998;14(3):171-9.

  17. Harrison LE, Karpeh MS, Brennan MF. Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach. Ann Surg. 1997;225:678, discussion 683.

  18. De Vita V, Hellman S, Rosemberg SA. Cancer: Principles and Practice of Oncology 6 - on CD-ROM. 6th. edition. Filadelfia: Lippincot & Wilkings and Williams; 2001. p. 354-401.

  19. Wang X, Wan F, Pan J, Yu GZ, Chen Y, Wang JJ. Tumor size: a non-neglectable independent prognostic factor for gastric cancer. J Surg Oncol. 2008 Mar 1;97(3):236-40.

  20. Harrison's. Principles of Internal Medicine. 15th edition. Part six-Oncology and Hematology. Section 1-Neoplastic Disorders. 83. Angiogenesis. On CD-ROM. México DF; 2001. p. 514-33.

  21. Del Casar JM, Corte MD, Álvarez A, García I, Bongera M, González LO, García- Muñiz JL, Allende MT, Astudillo A, Vizoso FJ. Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. 2008 Feb;134(2):153-61.




2020     |     www.medigraphic.com